01. Pre-Meeting Briefing prepared by NICE

02. Submission from the technology manufacturer Biogen Idec

03. Patient Access Scheme from the Manufacturer

04. NICE request to the manufacturer for clarification on their submission

05. Manufacturer clarification response

06. Consultee submission -  The Multiple Sclerosis Society

07. Consultee submission - The Multiple Sclerosis Trust

08. Consultee submission - The Association of British Neurologists

09. Consultee submission - The Royal College of Pathologists

10. Consultee submission - The United Kingdom Clinical Pharmacy Association

11. Patient expert personal perspective from Catherine John

12. Patient expert personal perspective from Nick Rijke

13. Clinical expert personal perspective from Dr Jacqueline Palace

14. Patient expert personal perspective from Professor Neil Robertson

15. Evidence Review Group report prepared by York Centre for Reviews and Dissemination and Centre for Health Economics

16. Errata to the Evidence Review Group report

17. Addendum  to the Evidence Review Group report

18. Manufacturer factual accuracy check of Evidence Review Group report

Please be advised that the format of evaluation reports shared on the NICE website has recently changed, for ease of user navigation between individual documents contained in the report.

It is a requirement of the new (PDF portfolio) format that Adobe Reader is used to view the document. Please follow the link at the bottom of this page to download Adobe Reader if required.

If you have any feedback on the new format please contact the Project Manager for this appraisal.

* Users of Google chrome should click the link below and then click the small PDF icon in the far right of the address bar to successfully access this document *